Takeda Pharmaceutical
TAK
#408
Rank
C$85.68 B
Marketcap
C$26.83
Share price
0.21%
Change (1 day)
31.88%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2026 (TTM): -C$0.17 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are C$29.54 Billion. In 2025 the company made an earning of C$4.72 Billion, an increase over its 2024 earnings that were of C$3.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.17 Billion-103.44%
2025 C$4.72 B49.03%
2024 C$3.16 B-2.41%
2023 C$3.24 B-28.14%
2022 C$4.51 B-40.9%
2021 C$7.64 B78.24%
2020 C$4.28 B246.1%
2019 C$1.23 B-48.79%
2018 C$2.41 B-23.64%
2017 C$3.16 B21.7%
2016 C$2.60 B-253.01%
2015 -C$1.71 Billion-159.65%
2014 C$2.85 B13%
2013 C$2.52 B2.46%
2012 C$2.46 B-57.05%
2011 C$5.73 B-10.49%
2010 C$6.40 B-3.99%
2009 C$6.67 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$37.20 B-21,333.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.03 B-12,675.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$9.80 B-5,695.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$14.60 B-8,434.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.16 B-5,901.19%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$10.91 B-6,330.35%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$11.20 B-6,491.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-C$1.13 Billion 540.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
C$0.71 B-507.73%๐Ÿ‡ฎ๐Ÿ‡ณ India